NAUTILUS BIOTECHNOLOGY

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

02 май 2023 06:30:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

18 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

23 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Announces “First Access Challenge” Winners

07 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

23 фев 2023 06:05:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

21 фев 2023 08:00:02 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

26 янв 2023 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Expands to San Diego

26 янв 2023 07:45:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

19 янв 2023 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Launches “First Access Challenge”

16 ноя 2022 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

01 ноя 2022 06:05:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

05 окт 2022 08:00:02 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

23 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

01 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

30 авг 2022 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

02 авг 2022 06:48:06 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development

01 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

13 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports First Quarter 2022 Financial Results

03 май 2022 06:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development

12 апр 2022 08:00:03 Источник Nasdaq GlobeNewswire